Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries

Respiratory syncytial virus (RSV) infection occurs commonly in infants aged ≤2 years, and severe infection results in hospitalization with accompanying morbidity and mortality. Palivizumab has been available for prophylaxis for the past 15 years. Prospective data on patients who received palivizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Paes, Bosco, Mitchell, Ian, Li, Abby, Harimoto, Tetsuhiro, Lanctôt, Krista L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703731/
https://www.ncbi.nlm.nih.gov/pubmed/23861694
http://dx.doi.org/10.1155/2013/917068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703731/
https://www.ncbi.nlm.nih.gov/pubmed/23861694
http://dx.doi.org/10.1155/2013/917068

Ejemplares similares